Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1Phase 1/2 1

Status

Active not recruiting 2Terminated 1Recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Other hematologic neoplasm 4

Conditions

Neoplasms 6Breast Neoplasms 5Prostatic Neoplasms 4Hematologic Neoplasms 4Colorectal Neoplasms 4Melanoma 3Lung Neoplasms 3Pancreatic Neoplasms 2Malignant Solid Neoplasm 2Leukemia, Myeloid, Acute 2Hematopoietic and Lymphatic System Neoplasm 2Head and Neck Neoplasms 2COVID-19 2Urologic Neoplasms 1Urologic Diseases 1Urinary Bladder Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Spondylitis, Ankylosing 1Speech 1Seroma 1Rectal Neoplasms 1Psoriasis 1Progressive Metastatic Castrate Resistant Prostate Cancer 1Postoperative Complications 1Peritoneal Neoplasms 1Parotid Neoplasms 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Lymphoma, T-Cell 1Lymphoma, Large-Cell, Anaplastic 1

Interventions

Cyclophosphamide 6fludarabine 4Standard of Care 4Practice Guidelines as Topic 3Mycophenolic Acid 3GSK2636771 3venetoclax 2trametinib 2talquetamab 2osimertinib 2dabrafenib 2X-Rays 2Whole-Body Irradiation 2Thiotepa 2Tacrolimus 2Specimen Handling 2Mesna 2Melphalan 2Magnetic Resonance Spectroscopy 2Filgrastim 2Biopsy 2ulixertinib 1trastuzumab biosimilar HLX02 1thymoglobulin 1sapanisertib 1ruxolitinib 1relatlimab 1plerixafor 1pertuzumab 1pembrolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Hematologic Neoplasms × Standard of Care × 30 days × Clear all
NCT03486873 2026-06-05

MK-3475-587

Merck Sharp & Dohme LLC

Phase 3 Recruiting
3,500 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

NCT04630431 2026-06-04

Understanding Challenges, Behavioral Patterns, and Preferences Toward Participation in Clinical Trials in Minority Patient Populations: Development of a Personalized Clinical Trial Educational Platform to Increase Participation in Clinical Trials Among Underserved Cancer Patients

Mayo Clinic

Phase NA Terminated
590 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

NCT04565665 2026-05-20

Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia

M.D. Anderson Cancer Center

Phase 1/2 Active not recruiting
65 enrolled
Other hematologic neoplasm

COVID-19, Hematologic Neoplasms

NCT05102656 2026-05-20

Patient Perceptions of the Relational Empathy of Healthcare Practitioners From the Department of Emergency Medicine During the COVID-19 Pandemic

M.D. Anderson Cancer Center

Phase NA Active not recruiting
107 enrolled
Other hematologic neoplasm

COVID-19, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡